Type, location and zygosity of KCNJ16 mutations may determine the clinical severity of Hypokalemic Tubulopathy and Deafness (HkTD)
Authors:
- Leire GondraLGLeire Gondra
- Shivani MoraSMShivani Mora
- Imran G ShaikhISImran G Shaikh
- Alejandro Garcia-CastañoAGAlejandro Garcia-Castaño
- Franziska SchillingFSFranziska Schilling
- Gema AricetaGAGema Ariceta
- Leire García-SuarezLGLeire García-Suarez
- Patricia Tejera-CarreñoPTPatricia Tejera-Carreño
- Gema Fernández-JuarezGFGema Fernández-Juarez
- Alfredo Santana RodríguezARAlfredo Santana Rodríguez
- Jonai Pujol-GiménezJPJonai Pujol-Giménez
- Marta García-AlonsoMGMarta García-Alonso
Preprint
Abstract
The pivotal role of K ir 5.1 ( KCNJ16 ) in maintaining electrolyte and acid-base homeostasis was demonstrated by animal studies and highlighted by the identification of disease-causing mutations in KCNJ16 resulting in a complex tubulopathy with variable severity. Although the underlying molecular mechanisms remain elusive, the modus operandi of K ir 5.1 is rooted in its heteromeric association with K ir 4.1 ( KCNJ10 ) and K ir 4.2 ( KCNJ15 ). The ubiquitous expression of KCNJ16 and the heterogenous clinical picture point towards the importance of protein-protein interactions and membrane trafficking of the heteromeric channels involving K ir 5.1. Alongside a retrospective report on the R137C variant, we describe a divergent clinical phenotype in a patient compound heterozygous for I132R and R176*. Moreover, we characterize a novel variant (homozygous for K48* and Y57*) whose clinical presentation coincides with the phenotype of the Kcnj16 -/- mouse model (lack of deafness). Functional studies, buttressed by biomolecular studies (imaging and Co-IPs) in mammalian cells emphasize that the type and location of the KCNJ16 mutations may determine their interaction, membrane localization, and consequently, channel function and the resulting clinical phenotype. Our study highlights the need for molecular understanding of the KCNJ16 variants to promote correct diagnosis and personalized therapies, especially those involving channel modulators.Keywords
This publication has 36 references indexed in Scilit:
- Electrochemical coupling at the plasma membrane by mouse voltage-sensitive phosphatase requires association with basiginCell Reports, 2025
- Deletion of Kcnj16 altered transcriptomic and metabolomic profiles of Dahl salt-sensitive ratsiScience, 2024
- A versatile functional interaction between electrically silent KV subunits and KV7 potassium channelsCellular and Molecular Life Sciences, 2024
- Novel KCNJ16 variants identified in a Chinese patient with hypokalemic metabolic acidosisMolecular Genetics & Genomic Medicine, 2023
- Inwardly rectifying potassium channel 5.1: Structure, function, and possible roles in diseasesGenes & Diseases, 2021
- Defective bicarbonate reabsorption in Kir4.2 potassium channel deficient mice impairs acid-base balance and ammonia excretionKidney International, 2020
- Gitelman syndrome: consensus and guidance from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceKidney International, 2017
- PSD-95 Mediates Formation of a Functional Homomeric Kir5.1 Channel in the BrainNeuron, 2002
- Functional implications of mutations in the human renal outer medullary potassium channel (ROMK2) identified in Bartter syndromePflügers Archiv - European Journal of Physiology, 2002
- Nonsense-Mediated mRNA Decay in Xenopus Oocytes and EmbryosDevelopmental Biology, 1994